About Us
ArisPharma is a chemistry-based company engaged in custom synthesis and manufacturing, and pharmaceutical and chemical research. We perform laboratory scale synthesis for pharmaceutical companies, drug discovery and "virtual" companies, biotechnology companies, and academic institutions.
We also carry out in-house novel anti-viral drug research programs, including the first in class small molecular HIV long term inactivators, which can actively attack virus in the absence of targeted cells. Along with our close collaborators, we have pioneered the study of small molecule HIV fusion inhibitor targeting gp41.
Why Us?
Specialized in quickly providing high quality pharmaceutical chemicals in custom pack sizes to satisfy any quantity required.
- - Distribute to companies worldwide
- - A dedicated professional customer service team positioned to ensure customer satisfaction and technical support
- - Provides special pricing for customers interested in bulk quantities
- - Provides custom synthesis - If the product you need is not in our catalogue, we can manufacture in a timely manner
- - Perform lab-scale research in our 5,000 square foot "state-of-the-art" laboratory, located in Levittown PA
Recent Publication/Patent by ArisPharma
Combining metformin and nelfinavir exhibits synergistic and complementary effects against growth of human cervical cancer cells and xenograft in nude mice
Cancer Letter,2016
Respiratory Syncytial Virus Entry Inhibitors Targeting the F Protein
VIRUSES-BASEL,2013
Introduction to the biological background of our current drug discovery program focusing on fusion mechanism of Respiratory Syncytial Virus
A novel synthetic/manufacturing process towards oxazole 2-derivatives
CN 201410117771.9
The application of benzamides in the preparation of drugs to activate the latent HIV
CN 201310103416.1
sales@arispharma.com
Tel: (800) 230-3521 
FAX: 1-267-395-2279